Area of research
Neurology · Cancer Research
Research interest
Research focused on Neuroblastoma and Hazard ratio, with related work in WNT5A, Neural crest, Proportional hazards model. Notable publications include 'Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers', 'WNT5A Encodes Two Isoforms with Distinct Functions in Cancers', and 'TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma'.
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable <i>MYCN</i>-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
Regulation by miR181 Family of the Dependence Receptor CDON Tumor Suppressive Activity in Neuroblastoma
WNT5A Encodes Two Isoforms with Distinct Functions in Cancers